Depression Symptoms clinical trials

Explore recruiting depression symptoms clinical trials.

Recruiting depression symptoms studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Depression Symptoms trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Exploring the Pharmacomicrobiomics of Depression

Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

C5541010 - A PHASE 2A, RANDOMIZED, DOUBLE BLIND, SPONSOR OPEN, PLACEBO CONTROLLED, PARALLEL GROUP, DOSE-RANGING STUDY OF PF 07976016 TO ASSESS SAFETY AND EFFICACY IN ADULT PARTICIPANTS WITH OBESITY

Hungary, Poland

Therapeutic exploratory (Phase II) EU CTIS Study details

PILOT STUDY ON THE EFFECTIVENESS OF CHOLINE ALFOSCERATE IN THE UNDER THRESHOLD DEPRESSION OF THE ELDERLY

Italy

Therapeutic use (Phase IV) EU CTIS Study details

Effects of intranasal oxytocin in the treatment of benzodiazepine withdrawal: A pilot randomized parallel group placebo-controlled trial

Norway

Therapeutic exploratory (Phase II) EU CTIS Study details

Adjuvant treatment with Pramipexole for anhedonia symptoms in depression - PRIME-PRAXOL

Sweden

Therapeutic confirmatory (Phase III) EU CTIS Study details

Women victims of violences : PTSD treatment by traumatic memory reactivation under the influence of propranolol (VIOFEM)

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Depression Symptoms trials by city

Depression Symptoms in Toronto Depression Symptoms in Vancouver Depression Symptoms in Montreal Depression Symptoms in Calgary Depression Symptoms in Edmonton Depression Symptoms in Ottawa Depression Symptoms in Winnipeg Depression Symptoms in Quebec City Depression Symptoms in Hamilton Depression Symptoms in Kitchener Depression Symptoms in London Depression Symptoms in Halifax Depression Symptoms in New York Depression Symptoms in Los Angeles Depression Symptoms in Chicago Depression Symptoms in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease